Dhanay M. Cadillo Chandler

1

Article

0

Comments
A medic administers a COVID-19 vaccine in Mumbai. India and South Africa have led efforts to get a waiver on intellectual property rights. Pratik Chorge/Hindustan Times via Getty Images

Intellectual property and COVID‑19 medicines: why a WTO waiver may not be enough

Enrico Bonadio, City St George's, University of London and Dhanay M. Cadillo Chandler, University of Turku

A waiver may not allow all developing countries to secure medicines and other anti-COVID technologies in a timely way.

Contact Dhanay for

  • General
  • Media request
  • Speaking request
  • Consulting / Advising
  • Research collaboration
  • Research supervision